The potential role of CD4+CD52lo T-cell populations in systemic lupus erythematosus.

[1]  K. Ichinose,et al.  CD4+ CD52lo T-cell expression contributes to the development of systemic lupus erythematosus. , 2017, Clinical immunology.

[2]  J. Harley,et al.  Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification , 2016, Annals of the rheumatic diseases.

[3]  Ming-jun Wang,et al.  Serum Levels of Three Angiogenic Factors in Systemic Lupus Erythematosus and Their Clinical Significance , 2014, BioMed research international.

[4]  L. Harrison,et al.  T cell regulation mediated by interaction of soluble CD52 with the inhibitory receptor Siglec-10 , 2013, Nature Immunology.

[5]  G. Tsokos,et al.  Systemic lupus erythematosus. , 2011, The New England journal of medicine.

[6]  Dennis B. Troup,et al.  NCBI GEO: archive for functional genomics data sets—10 years on , 2010, Nucleic Acids Res..

[7]  G. Tsokos,et al.  Pathogenesis of human systemic lupus erythematosus: recent advances. , 2010, Trends in molecular medicine.

[8]  Y. Takasaki,et al.  Levels of IL‐12 in the sera of patients with systemic lupus erythematosus (SLE)—relation to Th1‐ and Th2‐derived cytokines , 1999, Clinical and experimental immunology.

[9]  R. Wong,et al.  Reduced in vitro production of interferon-gamma, interleukin-4 and interleukin-12 and increased production of interleukin-6, interleukin-10 and tumour necrosis factor-alpha in systemic lupus erythematosus. Weak correlations of cytokine production with disease activity. , 1999, Autoimmunity.